Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection
about
Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data.Hepatitis C viremia patterns in incident hepatitis C infection and one year later in 150 prospectively tested persons who inject drugsEnding hepatitis C in the United States: the role of screening.Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies.The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Hepatitis C transmission and treatment in contact networks of people who inject drugs.Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan ChicagoSpontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysisHepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 StudyHigh rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.Human immunodeficiency virus and liver disease forum 2012.Novel interventions to prevent HIV and HCV among persons who inject drugs.Innate and Adaptive Immune Responses in Chronic HCV Infection.Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance.Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.Risk factors for familial clustering of hepatitis C virus infection in a Chinese Han population: a cross-sectional study.
P2860
Q26749249-6EF5018A-7872-4DC6-B5AF-2205136F8F6EQ30884457-1B400BD7-11FA-4EA0-88AC-C6232B9E4EB8Q33618436-75BD0110-13BE-4B80-8C2E-C843FF69F9D5Q33862919-FC867B64-79D2-44A8-90A9-8803C8D1D977Q33890011-85AAC983-FA7A-4989-8F28-BA08D1E53D4AQ34481429-16879A43-00FB-4596-89EF-5C3B41DFA613Q35040866-E760CB74-5C9F-4465-A483-752C24DE3BAEQ35752296-EB831E7E-1A0B-461E-8AB5-C964A9BAC7D9Q36123263-8C008B8F-46F1-4F8D-8818-E8A867B84761Q36148971-BCDD2A48-4EA4-4A67-A99E-57C11EC66FDEQ37288631-F6372A1B-0572-4022-AA34-3F3E04C3CCEBQ37361082-E59F056A-146C-450E-9D57-FDDD061BD23FQ38318678-F531A1D7-C03B-4E72-AFB6-D4D7E63DB1C0Q41035955-5E39CAAE-0887-4128-BF9A-52FED7FA90FAQ42226574-B57572B5-2DB4-4776-B8E2-34A5B9160E5CQ42720607-26C274F2-BD78-4F85-A0E4-BF331D647BFDQ55396689-2C298CC8-5923-4E56-94B5-A18022C5EE3A
P2860
Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Frequent longitudinal sampling ...... ctable viremia and reinfection
@ast
Frequent longitudinal sampling ...... ctable viremia and reinfection
@en
type
label
Frequent longitudinal sampling ...... ctable viremia and reinfection
@ast
Frequent longitudinal sampling ...... ctable viremia and reinfection
@en
prefLabel
Frequent longitudinal sampling ...... ctable viremia and reinfection
@ast
Frequent longitudinal sampling ...... ctable viremia and reinfection
@en
P2093
P2860
P50
P356
P1476
Frequent longitudinal sampling ...... ctable viremia and reinfection
@en
P2093
Alice Asher
Andrea L Cox
Jennifer Evans
Judith A Hahn
Leslie Tobler
William Osburn
P2860
P304
P356
10.1093/CID/CIS921
P407
P577
2012-10-22T00:00:00Z